Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Are the Key Projections for the CAGR of the Psychedelic Drugs Market Size From 2025 to 2034?
The size of the market for psychedelic drugs has seen a swift expansion in the past few years. Its growth is projected to surge, moving from $5.56 billion in 2024 to $6.33 billion in 2025. This represents a compound annual growth rate (CAGR) of 13.9%. Factors contributing to the growth witnessed in the historic period include changes in the regulatory environment, heightened awareness about mental health, and evolving public viewpoints.
The market size for psychedelic drugs is projected to experience exponential growth in the upcoming years, expanding to an estimate of $11.68 billion by 2029 with a Compound Annual Growth Rate (CAGR) of 16.5%. This surge in growth during the projection period can be attributed to several factors such as progress in drug development, broadening of therapeutic applications, the increasing acceptance within the medical fraternity, changes in public policy, and responses to mental health crises. The forecast period will also witness significant trends such as a concentration on educating the public and increasing awareness, evolution in legal and regulatory factors, the proliferation of psychedelic compounds, and an emphasis on patient-focused treatments.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=6345&type=smp
Which Primay Drivers Are Accelerating Growth in the Psychedelic Drugs Market?
The escalation in mental illness instances is projected to spur the expansion of the psychedelic drugs market in the future. Mental illnesses denote health conditions characterized by variations in feelings, cognition, or conduct; they encompass conditions like distress and post-traumatic stress disorder. Psychedelic drugs, used for treating depression and PTSD, can reduce the occurrence of mental illnesses with regular use. To illustrate, per the November 2022 data from the National Centre for Social Research, London-based social research institute indicated that the count of 17 to 19-year-olds suspected of having a mental disorder escalated from 17.4% in 2021 to 25.7% in 2022. Consequently, the escalating prevalence of mental health disorders is fuelling the growth of the psychedelic drugs market.
Which Primary Segments of the Psychedelic Drugs Market Are Driving Growth and Industry Transformations?
The psychedelic drugs market covered in this report is segmented –
1) By Type: Lysergic Acid Diethylamide (LSD), Ketamine, Phencyclidine, Gamma Hydroxybutyric Acid (GHB), Salvia
2) By Disease Indication: Depression, PTSD
3) By Origin: Natural, Synthetic
4) By Application: Treatment-Resistant Depression, Opiate addiction, Post- Traumatic Stress Disorder, Narcolepsy, Panic Disorders
5) By Distribution Channel: Hospitals Pharmacy, Retail Pharmacy, Online Pharmacy
Subsegments:
1) By Lysergic Acid Diethylamide (LSD): LSD Tablets, LSD Liquid, LSD Blotters
2) By Ketamine: Ketamine Infusion, Ketamine Nasal Spray, Ketamine Injectable
3) By Phencyclidine (PCP): PCP Powder, PCP Tablets, PCP Liquid
4) By Gamma Hydroxybutyric Acid (GHB): GHB Liquid, GHB Powder, GHB Capsules
5) By Salvia: Salvia Extract, Salvia Dried Leaves, Salvia Tinctures
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=6345&type=smp
Which Regions Are Key Players in the Growth of the #Which Primay Drivers Are Accelerating Growth in the Psychedelic Drugs Market?# Market?
North America was the largest region in the psychedelic drugs market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the psychedelic drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Which Technological Trends Are Reshaping the Psychedelic Drugs Industry Dynamics?
Leading organizations in the psychedelic drugs industry are concentrating their efforts on ground-breaking products like ketamine to enhance treatment results for mental health issues, augment patient access to therapy, and delve into new uses for psychedelic substances in areas such as depression, anxiety, PTSD, and substance use disorders. Known for its dissociative characteristics, ketamine is also used as an anesthetic and analgesic and is being studied for its instantaneous antidepressant effects in managing severe conditions like depression and PTSD. For example, Husch Blackwell, a conventional company headquartered in the US, introduced the Psychedelics and Emerging Therapies Practice Group in March 2022. This group is planned to support innovators in the research, development, and marketing of novel therapies derived from psychedelics. It includes a multidisciplinary group of solicitors proficient in navigating the complex legal environment surrounding these substances, often categorized as Schedule I controlled substances under U.S. federal law. This categorization presents considerable regulatory obstacles which can slow down research and development.
View the full report here:
https://www.thebusinessresearchcompany.com/report/psychedelic-drugs-global-market-report
What Parameters Are Used to Define the Psychedelic Drugs Market?
Psychedelic drug refers to a group of psychoactive drugs that alter perception, mood, and thought processes. All the senses are affected by psychedelics, which change a person’s thinking, perception of time, and emotions. These include chemicals such as Lysergic acid diethylamide (LSD) and plants such as peyote. These medications are used to treat a variety of brain conditions.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=6345
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model